—
Price
—
Market Cap
—
P/E Ratio
—
Forward P/E
—
EPS (TTM)
—
Dividend Yield
—
Cash
—
Total Debt
—
Shares Out
Institutional Ownership of Myovant Sciences
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Myovant Sciences
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2022-Q4 | |||||
| SELL | EXIT | — | — | — | |
| 2022-Q3 | |||||
| SELL | -3.0% | 79.2K | $1M | — | |
| 2022-Q2 | |||||
| BUY | +2.2% | 81.6K | $1M | — | |
| 2022-Q1 | |||||
| BUY | +45.3% | 79.9K | $1M | — | |
| 2021-Q4 | |||||
| SELL | -26.0% | 55.0K | $856000 | — | |
| 2021-Q3 | |||||
| BUY | +0.8% | 74.3K | $2M | — | |
| 2021-Q2 | |||||
| BUY | +16.5% | 73.7K | $2M | — | |
| 2021-Q1 | |||||
| BUY | +2.2% | 63.2K | $1M | — | |
| 2020-Q4 | |||||
| BUY | +1.0% | 61.9K | $2M | — | |
| 2020-Q3 | |||||
| BUY | +17.7% | 61.3K | $861000 | — | |
| 2020-Q2 | |||||
| BUY | NEW | 52.0K | $1M | — | |
Insider Trading for Myovant Sciences
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.